# Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study

> **NCT07275697** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Emma Svennberg** · enrollment: 200 (estimated)

## Conditions studied

- Atrial Fibrillation (AF)
- Obesity & Overweight

## Interventions

- **DRUG:** Semaglutide 2.4 mg
- **BEHAVIORAL:** Standard medical treatment

## Key facts

- **NCT ID:** NCT07275697
- **Lead sponsor:** Emma Svennberg
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-12-15
- **Primary completion:** 2028-12-30
- **Final completion:** 2028-12-30
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-12-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07275697

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07275697, "Waiting on Atrial Fibrillation Intervention Therapy (WAIT) Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07275697. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*